시장보고서
상품코드
1630703

요검사 시장 규모, 점유율, 성장 분석 : 검사별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)

Urinalysis Test Market Size, Share, Growth Analysis, By Test (Pregnancy & Fertility Tests, Biochemical Urinalysis), By Application (Disease Screening, Pregnancy and Fertility), By End User, By Region - Industry Forecast 2025-2032

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 220 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 요검사 시장 규모는 2023년에 24억 달러로 평가되며, 2024년 25억 1,000만 달러에서 2032년에는 35억 4,000만 달러로 확대하며, 예측 기간(2025-2032년)의 CAGR은 4.4%로 성장할 전망입니다.

요검사 시장은 의료기기, 특히 소변 분석기 및 관련 제품의 발전에 힘입어 급성장할 것으로 예상됩니다. 의료 인프라의 개선과 미충족 의료 수요 증가, 특히 당뇨병과 같은 만성질환의 유병률 증가는 소변 검사 솔루션에 대한 수요를 촉진하고 있습니다. 온주 국립보건원(NIH)이 실시한 대규모 소변 검사 등 정부가 시작한 검진 프로그램은 질병의 조기 발견을 강화하여 시장 확대를 더욱 촉진할 것으로 예상됩니다. 또한 남녀를 불문하고 요로 감염의 발생률이 증가함에 따라 당뇨병 및 다양한 신장질환의 진단에 중요한 역할을 하는 소변 검사의 필요성이 대두되고 있습니다. 전반적으로 소변 검사 시장은 신흥 시장에서 큰 성장을 이룰 것으로 예상됩니다.

목차

서론

  • 조사의 목적
  • 조사 범위
  • 정의

조사 방법

  • 정보 조달
  • 2차 데이터와 1차 데이터 방법
  • 시장 규모 예측
  • 시장의 전제조건과 제한

개요

  • 세계 시장 전망
  • 공급과 수요의 동향 분석
  • 부문별 기회 분석

시장 역학과 전망

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 촉진요인과 기회
    • 억제요인과 과제
  • Porter의 산업 분석

주요 시장 인사이트

  • 주요 성공 요인
  • 경쟁의 정도
  • 주요 투자 기회
  • 시장 에코시스템
  • 시장의 매력 지수(2024년)
  • PESTEL 분석
  • 거시경제 지표
  • 밸류체인 분석
  • 가격 분석

요검사 시장 규모 : 검사별

  • 시장 개요
  • 임신과 불임 검사
  • 요생화학적 검사
  • 요침사 검사

요검사 시장 규모 : 용도별

  • 시장 개요
  • 질환 스크리닝
  • 임신과 생식 능력

요검사 시장 규모 : 최종사용자별

  • 시장 개요
  • 병원·클리닉
  • 진단 검사실
  • 홈케어 환경
  • 조사실·연구소

요검사 시장 규모

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 이탈리아
    • 기타 유럽 지역
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카 지역
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 정보

  • 상위 5사의 비교
  • 주요 기업의 시장 포지셔닝(2024년)
  • 주요 시장 기업이 채택한 전략
  • 시장의 최근 동향
  • 기업의 시장 점유율 분석(2024년)
  • 주요 기업의 기업 개요
    • 회사 개요
    • 제품 포트폴리오 분석
    • 부문별 점유율 분석
    • 매출의 전년대비 비교(2022-2024)

주요 기업 개요

  • Cardinal Health(US)
  • General Electric Company(US)
  • Metropolis India(India)
  • 77 Elektronika Kft(Hungary)
  • Roche Diagnostics(Switzerland)
  • Thermo Fisher Scientific(US)
  • Sysmex Corporation(Japan)
  • Abbott(US)
  • Trinity Biotech(Ireland)
  • ARKRAY Inc.(Japan)
  • Dr Lal PathLabs(India)
  • F. Hoffmann-La Roche Ltd(Switzerland)
  • Siemens(Germany)
  • Sysmex Corporation(Japan)
  • BioMaxima SA(Poland)

결론과 권장사항

KSA 25.02.24

Global Urinalysis Test Market size was valued at USD 2.4 billion in 2023 and is poised to grow from USD 2.51 billion in 2024 to USD 3.54 billion by 2032, growing at a CAGR of 4.4% during the forecast period (2025-2032).

The urinalysis test market is poised for rapid growth, driven by advancements in medical equipment, particularly in urine analyzers and related products. Improved healthcare infrastructure and rising unmet health needs, especially the increasing prevalence of chronic diseases like diabetes, are propelling demand for urine testing solutions. Screening programs initiated by governments, such as the significant urine screenings conducted by the National Institute of Health (NIH) in Wenzhou, are enhancing early disease detection and are expected to further stimulate market expansion. Additionally, the rising incidence of urinary tract infections, prevalent in both genders, is fueling the necessity for urinalysis testing, which plays a critical role in diagnosing diabetes and various renal issues. Overall, the market for urine tests is set for significant growth in emerging markets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Urinalysis Test market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Urinalysis Test Market Segmental Analysis

Global Urinalysis Test Market is segmented by Application, End User, Test and region. Based on Test, the market is segmented into Pregnancy & Fertility Tests, Biochemical Urinalysis and Sediment Urinalysis. Based on Application, the market is segmented into Disease Screening and Pregnancy and Fertility. Based on End User, the market is segmented into Hospitals & Clinics, Diagnostic Laboratories, Home Care Setting and Research Laboratories & Institute. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Urinalysis Test Market

The global urinalysis test market is primarily driven by the increasing prevalence of diabetes and urinary tract infections (UTIs), particularly in developing countries. The surge in UTI cases poses significant health risks, as untreated infections can lead to complications during childbirth and may spread to the kidneys, highlighting the critical need for timely diagnosis and treatment. As awareness of these conditions grows, the demand for urinalysis tests is expected to rise, further propelling market growth. Additionally, improved access to healthcare services and advancements in diagnostic technologies are enhancing the overall landscape of the urinalysis test market.

Restraints in the Global Urinalysis Test Market

One of the key restraints in the global urinalysis test market is the limited accessibility to advanced urine analyzers, particularly in developing countries where cost is a major concern. In these regions, healthcare providers often opt for more affordable devices that offer similar functionalities, leading to increased demand for budget-friendly alternatives. Furthermore, the lack of robust regulatory frameworks can result in an influx of substandard and refurbished products in the market, undermining the quality of diagnostic services and potentially risking patient safety. This scenario creates significant challenges for manufacturers aiming to introduce high-quality, innovative solutions in these emerging markets.

Market Trends of the Global Urinalysis Test Market

The Global Urinalysis Test market is experiencing a notable trend driven by advancements in diagnostic technology, particularly through automated urine analyzers and smartphone-integrated testing devices. These innovations enhance the precision and accessibility of urinalysis, catering to both healthcare professionals and patients. As chronic illnesses such as diabetes and kidney disease rise, the demand for efficient urinalysis tests is surging, reinforcing their integral role in early health problem detection and management. This expanding requirement for streamlined testing methods emphasizes urinalysis as a cornerstone of modern healthcare, propelling market growth and innovation in diagnostic approaches for better patient outcomes.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Urinalysis Test Market Size by Test & CAGR (2025-2032)

  • Market Overview
  • Pregnancy & Fertility Tests
  • Biochemical Urinalysis
  • Sediment Urinalysis

Global Urinalysis Test Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Disease Screening
  • Pregnancy and Fertility

Global Urinalysis Test Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Home Care Setting
  • Research Laboratories & Institute

Global Urinalysis Test Market Size & CAGR (2025-2032)

  • North America (Application, End User, Test)
    • US
    • Canada
  • Europe (Application, End User, Test)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Application, End User, Test)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Application, End User, Test)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Application, End User, Test)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Cardinal Health (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • General Electric Company (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Metropolis India (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 77 Elektronika Kft (Hungary)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Diagnostics (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sysmex Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Trinity Biotech (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ARKRAY Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dr Lal PathLabs (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche Ltd (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sysmex Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioMaxima SA (Poland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제